Cochlear Implant Fitting Methods for Hearing Loss

(CALOS4 Trial)

No longer recruiting at 5 trial locations
AP
Overseen ByAnke Plasmans
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Cochlear
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores new ways to fine-tune cochlear implants for individuals who lost their hearing after learning to speak. It compares two fitting methods—behavioral fitting and categorical loudness scaling-based fitting—to determine which one enhances hearing and comfort. Individuals with a cochlear implant who experienced severe hearing loss after age two may qualify. Participants will try both fitting methods over several weeks, aiding researchers in improving future cochlear implant programming. As an unphased trial, this study allows participants to contribute to advancements in cochlear implant technology and improve outcomes for future users.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What prior data suggests that these cochlear implant fitting methods are safe?

Research shows that cochlear implants, which assist people with severe hearing loss, are generally safe. The Categorical Loudness Scaling method adjusts the implant by providing information about perceived sound loudness. Studies have not reported specific negative effects from this method.

For the Behavioural Fitting method, research indicates that cochlear implants are safe and effective. Most side effects from cochlear implant surgeries are minor and temporary. People typically adjust well to the device, enhancing their hearing and quality of life.

Overall, both methods for adjusting cochlear implants are well-tolerated and considered safe based on available research.12345

Why are researchers excited about this trial?

Researchers are excited about the trial for cochlear implant fitting methods because it explores innovative ways to enhance hearing outcomes for people with hearing loss. Unlike standard fitting techniques, which might not always perfectly match individual needs, this trial examines both behavioral fitting and categorical loudness scaling-based fitting. These methods aim to tailor the cochlear implant experience more precisely to each user, potentially leading to better sound perception and overall satisfaction. By offering a personalized approach, this trial could pave the way for more effective and user-friendly hearing solutions.

What evidence suggests that these cochlear implant fitting methods are effective for hearing loss?

Research has shown that two methods, categorical loudness scaling and behavioral fitting, are promising for effectively setting up cochlear implants. In this trial, participants will receive both categorical loudness scaling-based fitting and behavioral fitting. Categorical loudness scaling reliably provides consistent loudness levels across different sessions. This method adjusts implant settings based on user comfort, potentially improving hearing. Behavioral fitting enhances speech understanding and quality of life, particularly for older adults and children with cochlear implants. Both methods aim to improve hearing and quality of life by customizing implant settings to fit individual needs.678910

Who Is on the Research Team?

AP

Anke Plasmans

Principal Investigator

Cochlear

Are You a Good Fit for This Trial?

This trial is for adults over 18 who became deaf after age 2 and now have a CI600 or CI500 series cochlear implant. Participants must understand the language used in speech tests and agree to follow the study rules.

Inclusion Criteria

Unilaterally implanted with the CI600 Series (CI612, CI622, CI632) or CI500 series (CI512, CI522, CI532) cochlear implant
Willingness to participate in and comply with all requirements of the protocol
Willing and able to provide written informed consent
See 2 more

Exclusion Criteria

Subject who will be programmed with an acoustic component in the implanted ear
Pure tone average (average of unaided thresholds at 0.5, 1, 2 and 4 kHz) less than or equal to 30 dB HL and aided word score of more than 80% in the contralateral ear
Score below 3 on the screening subset of questions from the Mobile Device Proficiency Questionnaire
See 6 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive both Categorical Loudness Scaling Based Fitting and Behavioural Fitting with 4 weeks experience of both MAPS

4 weeks
Multiple visits for fitting and testing

Follow-up

Participants are monitored for performance outcomes and further refinement of fitting methods

4 weeks
Follow-up visits for outcome measures

What Are the Treatments Tested in This Trial?

Interventions

  • Behavioural fitting
  • Categorical loudness scaling based fitting
Trial Overview The study compares two ways of setting up cochlear implants: one uses behavioral fitting with Custom Sound Suite software, and the other uses loudness scaling with Nexus System. It's to find out which method works best post-activation.
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: Participants receiving both Categorical Loudness Scaling Based Fitting and behavioural fitting.Experimental Treatment2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

Cochlear

Lead Sponsor

Trials
96
Recruited
6,300+
Headquarters
Sydney, Australia

Dig Howitt

Cochlear

Chief Executive Officer since 2018

BE (Hons), MBA

Michael del Prado

Cochlear

Chief Medical Officer since 2022

MD, MSc, FRACP, FAAHMS, FAICD

QbD Clinical

Industry Sponsor

Trials
5
Recruited
400+

QbD Clinical

Collaborator

Trials
6
Recruited
460+

Avania

Industry Sponsor

Trials
59
Recruited
10,000+

Published Research Related to This Trial

Cochlear implants (CIs) effectively restore hearing in individuals with total sensorineural hearing loss by converting sound into electrical signals for the auditory nerve, but the current fitting process is often generic and may not optimize individual user outcomes.
To improve speech recognition variability among CI users, the authors propose using objective, patient-specific data and machine-learning algorithms to create personalized fitting procedures that account for individual differences in auditory system function and electrode activation.
Towards personalized and optimized fitting of cochlear implants.Van Opstal, AJ., Noordanus, E.[2023]
The study involved 10 profoundly hearing impaired children aged 2 to 7 years, and it demonstrated that multi-modal electrophysiological tests can effectively predict optimal comfort levels (M-Levels) for cochlear implant programming, especially in challenging cases where behavioral responses are hard to obtain.
Significant positive correlations were found between electrophysiological thresholds and behavioral comfort levels over the first year of implant use, indicating that this statistical method can reliably assist audiologists in creating effective cochlear implant maps (MAPs) when direct behavioral measurements are difficult.
Electrophysiological Correlates of Behavioral Comfort Levels in Cochlear Implantees: A Prospective Study.Raghunandhan, S., Ravikumar, A., Kameswaran, M., et al.[2020]
The study involving six Nucleus-22 cochlear implant users found that the relationship between loudness and electrical stimulation varies significantly among individuals, indicating a need for personalized mapping of acoustic amplitudes to electric currents.
Loudness growth was influenced by stimulation rate and electrode configuration, with some subjects showing nonlinear loudness responses at lower stimulation rates, suggesting that low-frequency stimulation may be processed differently across electrode locations.
Loudness growth in cochlear implants: effect of stimulation rate and electrode configuration.Fu, QJ.[2007]

Citations

and Post-Cochlear Implant: An Egyptian StudyThe present study aimed to detect the behavioral problems pre- and post-cochlear implantation in comparison to normal hearing group to be able to manage these ...
A behavioral method to estimate charge integration ...The present method offers a quick behavioral test with which to measure charge integration efficiency, which may be a useful measure of neural health.
Hearing and Quality-of-Life Outcomes After Cochlear ...Older adults in this study achieved clinically meaningful improvement in both speech perception and patient-reported quality-of-life metrics ...
Cochlear Implant Behavioral Outcomes for Children With ...Improvements in outcome performance were observed in all the included studies. Children with ANSD fit with CIs can achieve outcomes similar to children with ...
Factors impacting outcomes of cochlear implantation in ...Data were from 288 children with a mean age at implant of 2.74 years. Overall follow-up at 1 year was 59% and 51% at 2 years. Younger age at ...
Summary of Safety and Effectiveness Data (SSED)It is recommended that prior to cochlear implantation, individuals with SSD have at least two (2) weeks to one (1) month experience wearing ...
Evaluation of Safety and Effectiveness of the LISTENT LCI ...Cochlear implantation is safe and effective in restoring hearing and speech recognition abilities for individuals with severe to profound sensorineural hearing ...
Long-Term Device Satisfaction and Safety after Cochlear ...This study found significant relationships between daily device use and FG, wearing comfort and long-term safety (90 months).
Brazilian Society of Otology task force – cochlear implant ...CI is a safe device for auditory rehabilitation of patients with severe-to-profound hearing loss. In recent years, indications for unilateral hearing loss and ...
Hearing and Quality-of-Life Outcomes After Cochlear ...The implant surgery was generally well tolerated, with most adverse events being minor, temporary, and commonly associated with a cochlear ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security